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Diagnostic and Interventional Imaging (2015) 96, 111—114Figure 1. Enhanced chest and abdominal CT scan in the portal
phase, thin MIP (maximum intensity projection) coronal reconstruc-
tion. The thrombus extends into the inferior vena cava and the right
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Case  report
A  50-year-old  woman  with  past  history  of  aggressive
angiomyxoma  diagnosed  in  2002,  located  initially  in  the  right
ovary  and  treated  by  hysterectomy  and  bilateral  salpingo-
oophorectomy  was  referred  for  lower  limb  edema.  She  had
two  pelvic  recurrences  in  2003  and  then  in  2004,  which  were
treated  surgically  and  had  not  been  offered  any  speciﬁc
follow-up  since  the  last  recurrence.
In  March  2013,  she  developed  pain  and  edema  in  her  legs
and  underwent  lower  limb  venous  Doppler  ultrasound  which
showed  thrombosis  in  the  right  common  iliac  vein  extend-
ing  into  the  inferior  vena  cava.  As  the  thrombosis  had  not
improved  despite  effective  dose  anticoagulation  for  15  days,
imaging  was  proposed.
An  abdominal  and  pelvic  CT  without  and  with  iodine
enhancement  (70  seconds  and  3  minutes)  showed  a  bulky
pelvic  mass  on  the  right  side  in  contact  with  the  iliac  ves-
sels  measuring  12.5  ×  10  ×  9  cm,  and  extending  from  the
ischiorectal  fosse  to  the  sacral  promontory,  pushing  the
bladder  and  right  ureter  anteriorly.  Contrast  enhancement
was  late  and  heterogeneous.  The  thrombus  was  of  reduced
density  on  all  images,  without  enhancement  at  all  phases
of  the  investigation  (Fig.  1)  and  extended  from  the  right
iliac  vein  through  the  inferior  vena  cava  into  the  right
atrium.  The  distinction  between  tumor  thrombus  and  a  ﬁbrin
thrombus  could  not  be  made  from  CT  ﬁndings  alone  and
an  abdominal  and  pelvic  MRI  with  gadolinium,  centered  on
the  inferior  vena  cava  was  proposed  in  order  to  establish
that  the  thrombus  was  made  up  of  tissue.  The  investigation
included  T1  and  T2  weighted  images  without  fat  satura-
tion  in  the  axial  and  coronal  planes  and  3D  echo  gradient
T1  weighted  images  with  fat  saturation,  both  without  and
with  gadolinium  chelate  (2,  3,  5,  10  and  17  minutes)  in
the  same  planes.  The  pelvic  tumor  was  slightly  heteroge-
neous  and  hypointense  on  the  T1  weighted  images,  and
heterogeneous  and  hyperintense  on  the  T2  weighted  images
with  a  ‘‘layered’’  appearance  (Fig.  2).  The  pelvic  tumor
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 minutes  after  gadolinium  injection.  The  thrombus  was
ypointense  on  the  T1  weighted  images,  and  hyperintense
n  the  T2  weighted  images  compared  to  the  muscles  and
sointense  on  T2  compared  to  the  tissue  component  in  the
elvic  mass.  Local  contrast  uptake  was  found  late  within  the
hrombus  at  10  minutes  and  was  seen  better  at  17  minutes
fter  gadolinium  injection  (Fig.  3).
The  patient  initially  underwent  thrombectomy  through
 sternotomy  and  right  atriotomy  under  extracorporeal  cir-
ulation  in  order  to  reduce  the  risk  of  thromboembolism.
he  surgical  specimen  contained  only  tissue  which  was  not
dhering  to  the  inferior  vena  cava  wall  and  was  extracted
imply  by  traction  (Fig.  4).
In  a  second  operation  stage,  the  pelvic  mass  was  excised
nd  the  right  internal  iliac  vein  was  then  ligated.  The  patient
as  offered  but  refused  medical  treatment  with  an  LHRH
gonist.
r Masson SAS. All rights reserved.
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Figure 2. Pelvic MRI. Aggressive angiomyxoma characterization. a: unenhanced axial T1 weighted image without fat suppresion. The
tumor is hypointense and heterogenous relative to muscles (white arrow); b: axial unenhanced T2 weighted image without fat suppresion.





















































sith fat suppresion, 3 minutes after the injection of gadolinium. L
ppearance (white arrow).
Histopathological  analysis  showed  both  ﬁbrous,  myxoid
nd  vascular  tumor  proliferation  containing  relatively  non-
typical  round  or  oval  cells  with  no  mitoses,  which  on
mmunohistochemistry  labelled  strongly  for  estrogen  and
rogesterone  receptors  conﬁrming  a  diagnosis  of  tumor
hrombus  secondary  to  a  further  recurrence  of  the  aggres-
ive  pelvic  angiomyxoma.
iscussion
ngiomyxoma  is  usually  a  benign  tumor  that  displaces  neigh-
oring  organs  rather  than  invading  them.  It  is  more  common
n  women  and  mostly  develops  in  the  pelvis,  vulva  or  per-
neum  [1,2].  In  men,  it  may  develop  in  the  perineum  or
nguino-scrotal  region  [3].  Rarer  sites  have  been  described,
ncluding  the  pulmonary  artery  [4].  The  aggressive  nature  of
he  tumor  is  due  to  its  potential  to  inﬁltrate  pelvic  organs
nd  the  high  risk  of  postoperative  recurrence  [2]  which  was
stimated  to  be  47%  with  the  meta-analysis  reported  by  Chan
t  al.  on  106  patients,  71%  of  recurrences  occurring  dur-
ng  the  ﬁrst  three  years  [5].  Metastases  are  rare,  although
econdary  lymph  node,  peritoneal  and  lung  sites  have  been
escribed  [6,9].  In  our  case,  the  presentation  of  the  pelvic
umor  on  CT  and  MRI  was  consistent  with  ﬁndings  reported
n  the  literature.  The  pseudo-layered  late  enhancement  was
ue  to  the  ﬁbrous  component  in  the  tumor,  whereas  the
yxoid  and  ﬂuid  component  is  reﬂected  by  a  heterogeneous
ayered  or  whirl  hyperintensity  on  T2  weighted  images  [7].
Invasion  of  the  inferior  vena  cava,  however,  is  extremely




weterogenous enhancement of the tumor with a persitant layering
eported.  The  ﬁrst  was  a  38-year-old  woman  who  developed
nferior  vena  cava  thrombus  extending  into  the  right  cardiac
avities  which  could  not  be  shown  to  be  tissue  on  trans-
sophageal  echocardiography  or  CT  but  only  on  biopsy  [8].
he  second  was  a third  pelvic  recurrence  in  a 38-year-old
oman  with  extension  into  the  inferior  vena  cava  associated
ith  a  lung  metastasis  [9].  CT  showed  extensive  punctiform
ontrast  enhancement  in  the  thrombus  which  may,  accord-
ng  to  the  authors,  have  been  due  to  arterial  venous  ﬁstulae.
either  of  these  patients  had  MRI.  In  our  case,  MRI  sug-
ested  that  the  thrombus  was  made  up  of  tissue  as  a  result
f  the  relatively  late  3D  T1  weighted  appearances  at  10  and
7  minutes  after  gadolinium,  showing  focal  punctiform  areas
f  enhancement.  The  enhancement  was  difﬁcult  to  identify
s  the  thrombus  was  paucicellular  on  histology,  compared  to
he  predominant  myxoid  component.  This  is  an  amorphous
ubstance  which  does  not  enhance.  Histological  examina-
ion  of  the  pelvic  tumor  showed  no  histological  differences
ith  the  vena  cava  thrombosis  and  in  particular  the  propor-
ion  of  ﬁbrous  tissues  and  vessels  were  equivalent.  There
as,  however,  a  greater  proportion  of  myxoid  material  in
he  thrombus  compared  to  the  pelvic  tumor.  This  ﬁnding  may
xplain  the  difference  in  enhancement  kinetics  between  the
elvic  tumor  and  thrombus.  It  was  also  impossible  to  demon-
trate  on  imaging  whether  or  not  the  thrombus  was  adhering
o  the  wall.  Brunelle  et  al.  described  a  case  of  an  aggres-
ive  pelvic  angiomyxoma  in  a  51-year-old  female  patient  in
hom  a  multi-modal  examination  was  performed.  The  tumor
as  hyperintense  on  DWI  images  at  b0  and  b1000  with  a  high
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Figure 3. Abdominal MRI. Characterization of the inferior vena caval thrombus. a: unenhanced axial T1 weighted image without fat
suppresion. The thrombus is hypointense on the T1 weighted image (white arrow); b: axial unenhanced T2 weighted image without fat
suppresion. The thrombus is hyperintense on the T2 weighted image (white arrow); c: axial enhanced T1 weighted image with fat suppresion
17 minutes after the injection of gadolinium. Late punctiform enhancement of the thrombus (white arrow).
Figure 4. Macroscopic and microscopic aspects of the thrombus. a: photograph of the surgical specimen. The thrombus is made up
exclusively of tissue, moulding the inferior vena cava; b: histological section with HES staining. The thrombus is made up exclusively of low
































DC  of  2  ×  10—3  mm2/sec,  similar  to  what  is  found  in  myx-
id  tumors  [10].  The  dynamic  enhancement  examination  of
his  tumor  after  gadolinium  showed  gradual  enhancement
ith  no  plateau  or  washout,  suggesting  that  it  was  ﬁbrous  in
ature.
In  terms  of  treatment,  apart  from  wide  surgical  exci-
ion,  an  LHRH  agonist  in  a  hormone-dependent  aggressive
ngiomyxoma  may  reduce  tumor  volume  but  does  not  reduce
he  risk  of  recurrence  [2].  Our  patient  has  not  had  any  fur-
her  recurrences  to  date,  almost  one  year  after  the  episode
escribed  in  this  article.
onclusion
ggressive  angiomyxoma  is  a  histological  benign  tumor
hich  does,  however,  have  considerable  potential  to
nﬁltrate  neighboring  organs  and  carries  a  high  risk  of  post-
perative  recurrence.  MRI  follow  up  within  3  years  after
nitial  surgery  is  required  in  order  not  to  miss  a  bulky  recur-
ence,  which  may  remain  asymptomatic  for  long  periods
f  time.  New  treatments  with  LHRH  agonists  appear  to  be
romising  because  of  the  hormone-dependency  of  aggres-
ive  angiomyxoma,  in  both  reducing  tumor  volume  and
imiting  mutilating  surgery.
Endovascular  extension  of  the  tumor  is  extremely  rare
nd  it  was  only  possible  to  conﬁrm  that  the  thrombus
onsisted  of  tumor  by  MRI,  using  late  3D  echo  gradient  T1
eighted  images  over  10  minutes  after  gadolinium  injec-
ion.  This  diagnosis  enabled  optimal  vascular  and  oncologic
urgery  to  be  planned.
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